Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-08-18

FDA Approved: FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental ANDA for Fluoxetine by Teva Pharmaceuticals USA, Inc., authorizing a generic version of fluoxetine. The action formalizes the availa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluoxetine (Fluoxetine)

Snippet

SUPPL AP for FLUOXETINE (FLUOXETINE)